{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 13, "transaction_limit": 160, "filters": {"q": "", "ticker": "NAMS", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 13, "acquisition_count": 4, "disposal_count": 9, "acquisition_value": 1642100.0, "acquisition_value_label": "$1.6M", "disposal_value": 4393814.9, "disposal_value_label": "$4.4M", "net_value": -2751714.9, "net_value_label": "$-2.8M", "flow_tone": "negative", "largest_value_label": "$2.1M", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 13, "value": "6035914.9000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$6.0M"}], "days": [{"transaction_date": "2026-06-22", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 85.7}, {"transaction_date": "2026-07-20", "acquisitions": 2, "disposals": 5, "total": 7, "bar_width": 100.0}], "side_mix": {"acquisitions": 4, "disposals": 9, "acquisition_share": 30.8, "disposal_share": 69.2}}, "company_flows": [{"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "acquisitions": 4, "disposals": 9, "acquired_value": 1642100.0, "acquired_value_label": "$1.6M", "disposed_value": 4393814.9, "disposed_value_label": "$4.4M", "net_value": -2751714.9, "net_value_label": "$-2.8M", "acquisition_share": 30.8, "disposal_share": 69.2, "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}], "company_overview": [{"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "filings": 13, "acquisitions": 4, "disposals": 9, "acquired_value": 1642100.0, "acquired_value_label": "$1.6M", "disposed_value": 4393814.9, "disposed_value_label": "$4.4M", "net_value": -2751714.9, "net_value_label": "$-2.8M", "acquisition_share": 30.8, "disposal_share": 69.2, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}], "transactions": [{"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 70200.0, "share_price": 29.96, "transaction_value": 2103192.0, "fetched_at": "2026-07-30T22:01:34.649745+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 31885.0, "share_price": 31.05, "transaction_value": 990029.25, "fetched_at": "2026-07-30T22:01:34.659168+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 80000.0, "share_price": 11.17, "transaction_value": 893600.0, "fetched_at": "2026-07-30T22:01:34.653713+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 25000.0, "share_price": 11.9, "transaction_value": 297500.0, "fetched_at": "2026-07-30T22:01:34.646898+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 2915.0, "share_price": 31.71, "transaction_value": 92434.65, "fetched_at": "2026-07-30T22:01:34.651771+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 80000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:01:34.657341+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 25000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:01:34.655619+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 39700.0, "share_price": 30.2, "transaction_value": 1198940.0, "fetched_at": "2026-07-13T10:30:44.855914+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 25000.0, "share_price": 10.9, "transaction_value": 272500.0, "fetched_at": "2026-07-13T10:30:44.859083+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 15000.0, "share_price": 11.9, "transaction_value": 178500.0, "fetched_at": "2026-07-13T10:30:44.857480+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 300.0, "share_price": 30.73, "transaction_value": 9219.0, "fetched_at": "2026-07-13T10:30:44.854260+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:30:44.852080+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 25000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:30:44.860581+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}